≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

L02BX Other hormone antagonists and related agents

Endpoint Browser

RX_L02BX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — L02BX

1 out of 7 registries used, show all original rules.

1742

4. Check minimum number of events

Min. number of events 3
1742

5. Include endpoints

None

1742

6. Filter based on genotype QC (FinnGen only)

1742

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF3

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1742 - 1742
Unadjusted period prevalence (%) 0.77 - 0.77
Median age at first event (years) 73.35 - 73.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1484
Matched controls
14841
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
26.0
323.0
509
292
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
13.5
323.0
1069
2379
L02AE02
ATC
leuprorelin; implant, parenteral
19.2
323.0
753
753
L02BX02
ATC
degarelix; parenteral
2759.9
323.0
1144
19
116
Kela drug reimbursment
Prostate cancer
4432.6
323.0
1480
1052
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
236.2
323.0
1444
1966
H02AB02
ATC
dexamethasone; systemic
15.1
323.0
644
715
352
Kela drug reimbursment
Abiraterone and enzalutamide
184.0
323.0
485
39
Y77
ICPC
Malignant neoplasm prostate
52.9
323.0
915
437
L02BB03
ATC
bicalutamide; oral
22.1
323.0
593
434
C61
ICD-10 Finland
Malignant neoplasm of prostate
1613.2
323.0
1478
2042
M05BX04
ATC
denosumab; parenteral
65.1
323.0
639
170
163
Kela drug reimbursment
Abiraterone and enzalutamide
271.4
323.0
746
55
L02BB04
ATC
enzalutamide; oral
189.5
323.0
543
45
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
62.4
323.0
533
132
L02BX03
ATC
abiraterone; oral
996.4
323.0
563
9
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
11.0
312.4
702
1116
NK6AN
NOMESCO Finland
Total body bone isotope imaging
23.1
296.1
444
269
WF049
NOMESCO Finland
Radiotherapy of metastasis
20.3
280.2
440
301
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
84.2
253.1
281
41
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
20.5
249.2
388
252
A03FA01
ATC
metoclopramide; systemic, rectal
7.5
233.5
678
1488
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
138.1
231.3
243
21
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.8
212.2
910
3197
JN4BD
NOMESCO Finland
Extensive body CT
7.0
199.1
588
1264
XX3DW
NOMESCO Finland
Time consuming IT work
7.7
196.7
532
1005
Z51.5
ICD-10 Finland
Palliative care
8.8
182.3
435
665
WF002
NOMESCO Finland
Radical radiotherapy
8.6
181.2
442
700
JN4AD
NOMESCO Finland
Body CT examination
7.3
163.4
447
827
N02AA05
ATC
oxycodone; systemic
5.4
157.5
592
1630
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
13.8
153.1
277
243
XKD00
NOMESCO Finland
Uroflowmetry
4.4
152.1
857
3536
ZX112
NOMESCO Finland
Subcutaneous
17.8
146.5
237
157
3054
Kela drug reimbursment
NA
69.3
140.5
161
26
1523
Kela drug reimbursment
NA
69.3
140.5
161
26
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
10.5
139.4
290
335
L03AA13
ATC
pegfilgrastim; parenteral
17.9
136.1
219
142
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
9.0
128.9
295
400
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.0
128.0
710
2746
A04AA02
ATC
granisetron; systemic, transdermal
9.1
125.8
285
379
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
5.5
122.3
420
995
L03AA14
ATC
lipegfilgrastim; parenteral
41.2
118.5
149
40
SPAT1256
SPAT
Intramuscular and subcutaneous injection
3.6
117.8
969
5075
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
25.8
114.4
162
70
WF004
NOMESCO Finland
Palliative radiotherapy
12.5
105.6
198
181
L02AE04
ATC
triptorelin; parenteral
17.6
89.7
144
90
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
297.8
83.5
84
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.8
82.9
166
171
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
10.6
82.1
166
174
L02AE03
ATC
goserelin; implant
18.0
81.2
129
78
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
9.2
80.5
177
216
1CD02
NOMESCO Finland
NA
128.7
79.8
85
7
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
6.8
77.5
209
349
ZX090
NOMESCO Finland
Other technic of radiotherapy
9.1
73.1
161
196
A79
ICPC
Malignancy NOS
17.9
69.3
110
66
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
37.3
68.8
88
25
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
9.3
62.3
134
156
WZC30
NOMESCO Finland
Teaching
3.3
61.6
366
1333
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.9
57.5
262
767
H02AB06
ATC
prednisolone; systemic
2.4
54.9
838
5248
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
49.2
54.7
66
14
G03HA01
ATC
cyproterone; systemic
15.1
53.4
90
63
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.8
52.4
415
1809
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
30.1
51.4
69
24
2BX02
NOMESCO Finland
NA
43.1
50.1
62
15
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
504.0
49.7
49
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
35.1
49.5
64
19
ZX120
NOMESCO Finland
Intravenous
3.4
47.2
258
866
R33
ICD-10 Finland
Retention of urine
2.9
46.9
332
1336
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
32.8
45.8
60
19
A06AH03
ATC
naloxegol; oral
12.0
45.6
85
75
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
45.1
325
1319
XJH00
NOMESCO Finland
Transanal ultrasonography
2.9
44.9
317
1270
J01MA02
ATC
ciprofloxacin; systemic
2.2
44.4
769
4909
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
6.8
44.4
116
182
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
7.0
42.9
110
168
A04AA01
ATC
ondansetron; systemic, rectal
4.3
42.8
168
423
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.5
42.8
160
384
Y06
ICPC
Prostate symptom/complaint
4.0
42.6
183
501
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
115.9
42.0
45
*
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
35.0
41.8
54
16
SPAT1254
SPAT
Administration of medicine
2.7
41.7
323
1363
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
23.6
41.2
59
26
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
13.2
41.1
73
58
H02AB07
ATC
prednisone; oral
2.9
41.0
289
1148
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
50.6
40.9
49
10
G04CA02
ATC
tamsulosin; oral
2.1
39.0
830
5659
XX1XQ
NOMESCO Finland
Other SPECT-CT
108.0
38.9
42
*
ZX080
NOMESCO Finland
Image guided radiotherapy
8.5
38.3
86
107
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
16.1
38.1
62
40
A02BC02
ATC
pantoprazole; systemic
2.1
38.0
1012
7517
WW500
NOMESCO Finland
Blood transfusion
4.5
37.2
138
327
U77
ICPC
Malignant neopl urinary tract other
28.1
36.1
49
18
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
7.2
33.4
83
121
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
24.2
33.3
47
20
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
15.5
32.8
54
36
1CD04
NOMESCO Finland
NA
+∞
32.4
31
*
ZXC96
NOMESCO Finland
Robot assisted procedure
4.5
31.5
116
273
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.9
31.3
107
233
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
29.9
595
3807
KEB00
NOMESCO Finland
Biopsy of prostate
5.3
29.1
92
184
N02BE01
ATC
paracetamol; systemic, rectal
2.2
28.5
1270
10809
TKE10
NOMESCO Finland
Puncture of prostate
8.7
27.2
59
70
UKC02
NOMESCO Finland
Cystoscopy
2.0
27.1
456
2712
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
3.8
27.1
120
335
WF090
NOMESCO Finland
Profylactic radiotherapy
8.7
26.7
58
69
K62.7
ICD-10 Finland
Radiation proctitis
8.5
25.5
56
68
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.5
24.5
120
364
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
8.4
24.5
54
66
L03AA02
ATC
filgrastim; parenteral
4.9
24.5
82
175
5BX04
NOMESCO Finland
NA
38.2
24.0
30
8
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
7.7
23.5
55
74
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
13.7
23.3
40
30
A28
ICPC
Limited function/disability NOS
2.1
22.5
312
1702
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.0
21.7
70
144
KFC10
NOMESCO Finland
Bilateral orchiectomy
21.1
21.3
31
15
JN4CD
NOMESCO Finland
Very extensive body CT
3.2
20.9
113
369
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
24.6
20.9
29
12
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
3.8
20.7
90
248
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
7.9
20.6
47
61
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
12.2
20.6
37
31
WVA30
SPAT
NA
4.3
20.2
77
188
B01AB10
ATC
tinzaparin; parenteral
2.7
20.1
144
563
R31
ICD-10 Finland
Unspecified haematuria
2.0
19.9
300
1683
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
19.5
192
897
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
22.9
19.1
27
12
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
19.1
241
1259
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.1
18.5
104
349
SPAT1167
SPAT
Insertion of urinary catheter
3.1
18.4
107
368
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
3.2
17.8
96
314
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
17.8
507
3492
TKC22
NOMESCO Finland
Catheterisation instruction
3.4
17.7
89
276
R50.9
ICD-10 Finland
Fever, unspecified
2.0
17.5
245
1331
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
17.4
765
5909
ZXC20
NOMESCO Finland
Use of chemical agents
3.9
16.7
70
187
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.6
16.6
75
214
Y50
ICPC
Male Genital, Medication/prescr/renewal
16.5
16.6
26
16
WF099
NOMESCO Finland
Other radiotherapy
10.2
16.4
32
32
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
16.3
195
990
A50
ICPC
General and Unspecified, Medication/prescr/renewal
3.6
16.3
74
212
J01MA12
ATC
levofloxacin; systemic
1.8
16.3
361
2293
U08
ICPC
Urinary retention
3.6
16.1
74
215
TQX05
NOMESCO Finland
Skin puncture, unspecified location
21.2
16.0
23
11
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.7
15.9
40
61
G04BD12
ATC
mirabegron; oral
2.1
15.5
199
1039
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
6.1
15.5
42
71
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.0
15.5
90
311
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
38.5
15.4
19
5
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.3
15.2
40
65
KE1BG
NOMESCO Finland
MRI of prostate
5.7
15.2
43
77
Z51.0
ICD-10 Finland
Radiotherapy session
5.4
14.9
44
83
ZX050
NOMESCO Finland
Stereotactic radiotherapy
6.5
14.5
37
58
L02BB01
ATC
flutamide; oral
9.5
14.5
29
31
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
6.3
14.4
38
62
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.8
14.2
32
42
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
30.3
13.9
18
6
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
14.9
13.6
22
15
A98
ICPC
Health maint/preventive medicine
1.9
13.6
1329
12184
SPAT1088
SPAT
Blood transfusion
6.9
13.5
33
49
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
3.6
13.4
60
171
J01DB01
ATC
cefalexin; oral
1.6
13.4
1126
9855
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
5.3
13.4
40
77
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
13.3
183
984
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
13.2
186
1009
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
13.2
135
639
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
12.8
343
2282
KE1CG
NOMESCO Finland
Extensive MRI of prostate
5.8
12.7
35
61
ECB20
NOMESCO Finland
Oral alveoplasty
5.6
12.7
36
65
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
12.6
326
2146
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
70.5
12.6
14
*
Y78
ICPC
Malign neopl male genital other
24.5
12.5
17
7
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.5
12.1
35
65
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
10.1
12.0
23
23
NK6SN
NOMESCO Finland
Bone SPECT
11.8
11.8
21
18
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
11.8
11.8
21
18
A06AD11
ATC
lactulose; oral
1.7
11.7
252
1572
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
4.4
11.6
41
95
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
4.8
11.5
37
78
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
35.3
11.3
14
*
S50
ICPC
Skin, Medication/prescr/renewal
6.0
11.2
30
51
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
4.1
11.1
42
104
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
9.3
11.0
22
24
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
11.0
426
3094
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
10.9
86
357
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
10.9
137
707
B01AB05
ATC
enoxaparin; parenteral
1.5
10.9
461
3409
KA3EB
NOMESCO Finland
Antegrade pyelography
7.2
10.8
25
35
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
10.6
120
596
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
14.3
10.5
17
12
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
14.3
10.5
17
12
B03XA02
ATC
darbepoetin alfa; parenteral
3.3
10.5
52
163
U04
ICPC
Incontinence urine
2.6
10.4
77
310
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
10.4
200
1200
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.2
10.4
53
169
U13
ICPC
Bladder symptom/complaint other
3.3
10.3
50
154
A55
ICPC
General and Unspecified, Local injection/infiltration
5.6
10.3
29
53
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
10.7
10.3
19
18
U28
ICPC
Limited function/disability (U)
4.3
10.0
36
86
J01EA01
ATC
trimethoprim; systemic
1.7
9.9
220
1379
KDE20
NOMESCO Finland
Removal of foreign body from urethra
4.2
9.9
36
87
EDW99
NOMESCO Finland
Other operation on mandible
20.2
9.8
14
7
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
9.8
1136
10189
-50
ICPC
Medication/prescr/renewal
2.5
9.8
76
315
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
9.6
9.8
19
20
A04AA55
ATC
palonosetron, combinations; systemic
5.3
9.5
28
54
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
6.7
9.4
23
35
M05BA08
ATC
zoledronic acid; parenteral
30.2
9.4
12
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
9.2
112
573
SPAT1154
SPAT
Insertion or removal of subcutaneous medicine capsule
13.8
9.2
15
11
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
3.4
9.2
43
130
ZX100
NOMESCO Finland
Oral
3.9
9.1
36
94
G04BE03
ATC
sildenafil; oral
2.7
9.1
59
222
SPAT1263
SPAT
Sampling
1.4
9.1
573
4557
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
8.9
392
2903
L95
ICPC
Osteoporosis
4.7
8.9
29
63
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
8.0
8.9
19
24
5BA08
NOMESCO Finland
NA
8.0
8.9
19
24
L01XX11
ATC
estramustine; systemic
9.5
8.8
17
18
KC1GB
NOMESCO Finland
Cystography with X-ray
3.3
8.7
41
125
C03CA01
ATC
furosemide; systemic
1.4
8.7
516
4052
HB000
NOMESCO Finland
Profylactic radiotherapy of mammary gland
11.6
8.6
15
13
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
27.7
8.5
11
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
27.7
8.5
11
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.0
8.5
22
37
WGA10
NOMESCO Finland
Measurement of pain intensity
90.5
8.4
9
*
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
7.9
8.4
18
23
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
8.3
8
*
KED22
NOMESCO Finland
Transurethral resection of prostate
1.7
8.2
193
1230
R06AE07
ATC
cetirizine; oral
1.4
8.1
397
2996
WX290
NOMESCO Finland
Other blockade of nerve
1.4
8.1
432
3314
K10.25
ICD-10 Finland
Sequences of jawbones
8.2
8.1
17
21
SPAT1255
SPAT
Intravenous administration of medicine
1.9
8.1
119
653
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
8.0
225
1501
U07
ICPC
Urine symptom/complaint other
2.1
7.9
83
401
N30.4
ICD-10 Finland
Irradiation cystitis
13.1
7.9
13
10
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.7
7.8
51
194
N02AA03
ATC
hydromorphone; systemic, rectal
9.5
7.8
15
16
SPAT1109
SPAT
Analgesia with portable analgesic pump
5.3
7.7
22
42
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
6.7
7.6
18
27
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
11.9
7.6
13
11
R60.0
ICD-10 Finland
Localized oedema
1.7
7.6
163
1012
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
25.1
7.6
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.1
7.6
39
128
G04CA01
ATC
alfuzosin; oral
1.5
7.5
339
2515
A07EA02
ATC
hydrocortisone; rectal
3.1
7.5
39
129
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.3
671
5624
WX110
NOMESCO Finland
Local anesthesy
1.3
7.3
833
7224
-55
ICPC
Local injection/infiltration
5.2
7.2
21
41
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
15.8
7.2
11
7
SPAT1262
SPAT
Handing over of treatment supplies
1.5
7.2
320
2363
L28
ICPC
Limited function/disability (L)
1.5
7.1
232
1604
130
Kela drug reimbursment
Malignant tumour
0.5
7.0
53
1033
Z43.5
ICD-10 Finland
Attention to cystostomy
4.6
6.9
22
48
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.8
242
1705
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
4.3
6.7
23
54
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.8
6.7
40
145
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.4
6.7
54
232
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
6.6
282
2064
N05CD07
ATC
temazepam; oral
0.6
6.5
72
1252
G04BD08
ATC
solifenacin; oral
1.8
6.4
102
579
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.9
6.4
37
131
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
6.6
6.3
15
23
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
5.2
6.3
18
35
A21
ICPC
Risk factor for malignancy
11.1
6.3
11
10
EDA10
NOMESCO Finland
Biopsy of mandible
11.1
6.3
11
10
2AE02
NOMESCO Finland
NA
18.1
6.3
9
5
U29
ICPC
Urinary symptom/complaint other
2.5
6.1
45
185
WVA20
SPAT
NA
4.2
6.1
21
50
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
4.7
6.1
19
41
U50
ICPC
Urological, Medication/prescr/renewal
12.6
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768800) Prostate Pathology biopsy report
508
815
8.39
321.56
1.1
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
985
1752
11.64
307.65
2.8
2.0
nmol/l
2.2
13.0
251.29
812
1493
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1433
8123
5.31
175.88
16.8
6.7
umol/l
9.9
13.4
40.85
1415
7752
(3015377) Calcium [Moles/volume] in Serum or Plasma
1060
4912
3.96
172.12
11.2
3.3
mmol/l
2.3
2.3
0.02
995
4199
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1658
11519
10.11
136.34
20.9
8.2
u/l
105.3
81.1
18.61
1635
10851
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1337
8034
3.86
130.35
13.3
7.7
mmol/l
1.2
1.2
1.47
1133
6750
(3031040) Bacteria [#/volume] in Urine by Automated count
1467
9778
4.17
113.06
6.0
4.5
e6/l
275.9
1059.5
0.65
23
188
(3013650) Neutrophils [#/volume] in Blood by Automated count
1329
8360
3.49
111.39
18.8
8.8
e9/l
4.3
4.5
2.95
1234
7245
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1658
12227
8.38
108.78
19.8
5.4
ug/l
36.7
3.2
16.49
1604
10822
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1174
7346
2.83
89.79
9.6
6.7
mmol/l
1.2
1.2
5.69
1112
6645
(3026008) Bacteria identified in Urine by Culture
770
4133
2.55
76.86
4.0
3.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
828
4643
2.49
74.62
8.3
4.5
ph
7.4
7.4
1.30
202
916
(3037467) Urinalysis macro (dipstick) panel - Urine
1394
10072
2.92
71.70
5.1
4.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
920
5484
2.44
71.47
5.1
4.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1091
7042
2.47
70.56
6.9
5.5
g/l
33.4
34.3
5.46
1040
6532
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
518
2407
2.64
68.45
7.0
4.0
u/l
281.1
239.4
4.22
500
2274
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1360
9809
2.76
68.13
9.4
4.7
%
20.6
22.0
2.54
1048
5295
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1058
6915
2.35
63.79
5.0
3.3
ug/l
1.9
0.8
19.58
861
5070
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
570
2861
2.47
63.22
6.0
3.3
mmol/l
2.5
2.5
0.60
539
2497
(3002582) Erythrocytes [#/volume] in Urine
884
5406
2.29
61.73
4.7
3.7
e6/l
152.0
103.6
0.63
775
4352
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1651
13796
4.77
54.49
28.8
18.9
mg/l
32.3
30.2
1.61
1531
11484
(3030467) Casts [#/volume] in Urine by Automated count
795
4864
2.17
52.96
4.4
3.6
e6/l
0.5
0.5
0.07
684
3808
(3026782) Osmolality of Urine
634
3552
2.23
52.68
3.6
3.0
mosm/kgh2o
581.0
588.2
0.42
573
3029
(3000850) Epithelial cells [#/volume] in Urine
667
3820
2.21
52.42
3.4
2.8
e6/l
3.1
2.9
0.29
613
3372
(3018095) Leukocytes [#/volume] in Urine
909
5876
2.14
52.29
5.2
4.1
e6/l
127.5
111.5
0.14
788
4548
(3002030) Lymphocytes/100 leukocytes in Blood
1016
6995
2.09
47.76
6.5
6.2
%
22.2
24.8
11.10
944
6475
(40758558) Short blood count panel - Blood
621
3566
2.15
47.46
16.1
6.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
816
5294
2.02
43.94
6.2
5.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
736
4603
2.04
43.93
4.4
3.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
993
6906
2.02
43.86
6.4
6.4
%
8.8
9.3
3.35
928
6435
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
306
1351
2.53
42.87
7.5
4.6
mmol/l
1.2
1.2
0.00
287
1200
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
544
3069
2.12
42.69
1.9
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
984
6873
1.99
42.32
6.2
6.1
%
2.7
2.9
1.51
915
6383
(3018010) Neutrophils/100 leukocytes in Blood
980
6876
1.97
41.14
6.4
6.0
%
62.2
59.3
9.74
920
6395
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1015
7209
1.98
41.09
5.8
4.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
958
6693
1.96
40.46
6.2
6.0
%
0.6
0.6
2.66
896
6226
(3044640) Blood type and Crossmatch panel - Blood
768
5066
1.92
37.62
3.4
2.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1661
14569
4.01
37.44
22.2
11.7
u/l
23.5
27.4
6.13
1629
13922
(3035941) MCH [Entitic mass]
1686
14945
4.99
37.25
44.7
27.4
pg
30.5
30.7
6.07
1668
14673
(3007461) Platelets [#/volume] in Blood
1686
14945
4.99
37.25
45.0
27.5
e9/l
231.8
224.9
4.10
1663
14501
(3024731) MCV [Entitic volume]
1686
14947
4.98
37.20
44.8
27.4
fl
92.4
92.1
1.75
1668
14677
(3026361) Erythrocytes [#/volume] in Blood
1686
14947
4.98
37.20
44.9
27.5
e12/l
4.1
4.5
125.58
1660
14430
(3010813) Leukocytes [#/volume] in Blood
1686
14950
4.97
37.12
45.0
27.5
e9/l
6.7
7.1
4.48
1662
14433
(3000963) Hemoglobin [Mass/volume] in Blood
1686
14951
4.97
37.10
45.2
27.7
g/l
123.8
136.2
156.73
1666
14681
(3013826) Glucose [Moles/volume] in Serum or Plasma
1243
9685
1.99
35.91
5.2
5.4
mmol/l
7.0
7.0
0.37
1198
9182
(3019550) Sodium [Moles/volume] in Serum or Plasma
1664
14725
3.90
34.58
31.0
22.7
mmol/l
139.2
139.6
7.64
1639
14377
(3019198) Lymphocytes [#/volume] in Blood
1014
7443
1.87
34.49
6.4
5.8
e9/l
1.6
1.9
2.14
868
6465
(3023103) Potassium [Moles/volume] in Serum or Plasma
1665
14751
3.91
34.29
31.5
23.0
mmol/l
4.0
4.0
1.21
1639
14391
(3013115) Eosinophils [#/volume] in Blood
1017
7549
1.83
32.54
6.4
5.8
e9/l
0.2
0.2
10.18
862
6566
(3019225) pH of Specimen
333
1715
2.16
31.93
8.2
4.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1528
13053
2.39
31.92
33.3
18.0
ml/min/173m2
76.4
72.6
12.84
1432
10969
(3006315) Basophils [#/volume] in Blood
990
7330
1.81
31.51
6.2
5.7
e9/l
0.0
0.0
7.37
830
6278
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
613
3927
1.87
31.44
3.2
2.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
481
2859
1.94
30.97
4.1
3.4
e6/l
0.7
0.6
0.29
326
1742
(3001604) Monocytes [#/volume] in Blood
983
7288
1.80
30.89
6.2
5.6
e9/l
0.6
0.7
8.87
825
6223
(3032080) INR in Blood by Coagulation assay
1024
7765
1.77
28.99
10.8
12.2
inr
1.2
1.4
9.05
306
2112
(3021589) Normoblasts [#/volume] in Blood
871
6321
1.76
28.61
17.3
11.1
e9/l
0.0
0.0
0.17
735
5179
(40761511) CBC panel - Blood by Automated count
1592
14034
2.56
27.78
27.4
18.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
206
966
2.28
24.50
1.9
1.9
ug/l
2.5
2.5
0.00
185
847
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
473
3013
1.78
23.41
3.8
3.2
e6/l
1.1
0.9
0.85
315
1880
(3012095) Magnesium [Moles/volume] in Serum or Plasma
458
2904
1.78
22.96
3.2
3.4
mmol/l
0.8
0.8
0.34
441
2719
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
639
4461
1.68
22.57
2.0
2.2
mg/l
3.1
3.0
0.71
558
3783
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
644
4509
1.68
22.47
6.3
3.4
u/l
37.2
42.2
0.54
621
4280
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
354
2109
1.85
21.65
1.9
1.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
451
2892
1.75
21.55
2.3
2.8
umol/l
11.8
12.5
1.17
428
2692
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
351
2097
1.84
21.23
1.9
1.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
427
2711
1.76
21.06
2.1
2.8
g/l
2.1
2.2
5.85
397
2518
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
784
5860
1.61
20.58
3.5
3.3
ng/l
1825.9
1902.1
0.18
706
5189
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
216
1118
2.06
19.87
1.6
1.5
—
—
—
0
0
(3013512) EKG study
689
5075
1.59
18.70
4.4
4.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1018
8235
1.57
18.12
3.7
3.4
u/l
54.8
64.5
2.48
928
7490
(3009542) Hematocrit [Volume Fraction] of Blood
1344
11624
1.68
18.03
31.0
20.3
%
35.5
39.0
18.36
801
6902
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
398
2575
1.71
17.98
2.2
2.9
%
23.1
23.1
0.00
340
2192
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
164
807
2.14
17.17
2.1
1.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
556
4006
1.57
16.00
5.4
4.4
%
87.5
79.3
11.00
548
3929
(3001122) Ferritin [Mass/volume] in Serum or Plasma
730
5630
1.51
15.17
2.5
3.0
ug/l
481.6
198.5
13.02
667
5102
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
209
1173
1.89
15.08
1.7
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
148
747
2.07
14.47
2.0
1.8
—
—
—
0
0
(4035726)
233
1379
1.80
14.14
1.3
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
107
483
2.29
13.83
3.8
3.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
291
1886
1.65
12.64
2.9
4.3
ug/l
21.4
29.7
0.34
240
1606
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
60
214
2.87
12.61
2.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
213
1270
1.77
12.56
4.4
3.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
823
6665
1.45
12.55
4.2
4.3
ng/l
76.1
64.1
0.15
717
5429
(3009261) Glucose [Presence] in Urine by Test strip
856
6985
1.44
12.52
4.1
3.7
estimate
0.0
0.0
0.00
212
1299
(3003694) ABO and Rh group [Type] in Blood
511
3775
1.50
12.50
1.4
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
367
2532
1.57
12.28
5.9
7.2
mmol/l
104.3
104.6
0.60
360
2465
(3017181) Myelocytes/100 leukocytes in Blood
230
1412
1.72
12.23
2.4
4.1
%
1.9
0.8
5.36
114
482
(3021601) Nitrite [Presence] in Urine by Test strip
840
6853
1.44
12.17
5.5
4.8
estimate
0.0
0.0
0.00
223
1388
(3041096) Erythrocytes [Presence] in Urine by Automated
488
3588
1.50
12.16
4.1
3.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1239
10875
1.48
12.07
39.6
22.9
%
14.5
13.9
27.98
1229
10620
(3004809) Band form neutrophils/100 leukocytes in Blood
82
350
2.41
12.06
1.8
3.9
%
2.5
1.8
0.55
54
265
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
43
132
3.31
11.67
2.6
1.2
u/l
180.5
52.4
1.89
35
88
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
31
81
3.88
10.67
2.7
1.6
u/l
3.6
7.6
1.00
22
41
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
621
4909
1.41
10.19
2.6
2.7
u/l
51.0
59.2
6.16
585
4538
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
270
1809
1.58
10.11
3.1
3.0
ng/l
229.9
248.2
0.22
254
1660
(3027945) Reticulocytes/100 erythrocytes in Blood
354
2522
1.51
10.03
2.7
2.4
%
1.8
1.7
0.95
321
2218
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
95
468
2.09
9.94
1.2
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
749
6132
1.39
9.92
2.3
2.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
260
3732
0.64
9.63
1.6
1.7
mmol/l
1.5
1.3
2.39
200
3032
(3002179) Metamyelocytes/100 leukocytes in Blood
200
1265
1.66
9.45
2.3
4.0
%
1.4
0.6
3.88
77
341
(3035350) Ketones [Presence] in Urine by Test strip
826
6909
1.37
9.43
4.1
3.6
estimate
0.0
0.0
0.00
225
1356
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
200
1290
1.62
8.73
1.5
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
96
499
1.98
8.70
5.2
4.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
205
1333
1.61
8.66
2.4
4.2
%
0.3
0.1
2.25
104
451
(3025159) Blasts/100 leukocytes in Blood
193
1241
1.62
8.53
2.4
4.1
%
0.0
0.2
1.36
88
376
(3021447) Carbon dioxide [Partial pressure] in Venous blood
266
1860
1.51
8.12
3.3
4.1
kpa
5.6
5.8
3.89
259
1793
(3002032) Base excess in Venous blood by calculation
266
1863
1.50
8.06
3.3
4.1
mmol/l
1.7
1.8
0.31
204
1464
(3023520) Reticulocytes [#/volume] in Blood
273
1932
1.49
7.85
3.2
2.5
e9/l
68.9
66.8
0.43
216
1499
(40760892) CBC W Ordered Manual Differential panel - Blood
384
2900
1.42
7.83
4.0
4.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
86
450
1.96
7.68
1.3
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
52
224
2.36
7.59
1.8
4.1
%
62.3
58.7
0.43
30
139
(3021960) Folate [Moles/volume] in Serum or Plasma
532
4276
1.35
7.35
1.8
1.6
nmol/l
17.0
18.9
2.34
461
3643
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
74
374
2.02
7.30
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
74
374
2.02
7.30
1.6
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
332
2479
1.42
7.16
4.6
6.9
mmol/l
1.0
1.0
0.06
311
2329
(40768804) Tissue Pathology biopsy report
681
5694
1.32
7.14
2.1
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
139
865
1.66
7.00
4.4
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
639
5318
1.32
6.85
4.6
4.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
97
550
1.81
6.80
1.2
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
461
5661
0.75
6.52
3.2
3.3
mmol/l
7.4
8.1
4.21
358
4681
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
247
1779
1.45
6.45
3.5
3.0
umol/l
7.3
11.2
3.20
223
1608
(3012501) Base excess in Blood by calculation
82
449
1.87
6.44
3.2
5.9
mmol/l
1.8
2.5
2.04
46
307
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
22
65
3.42
6.42
1.2
1.1
u/l
36.8
44.6
0.22
17
43
(3012516) Albumin [Mass/volume] in Urine
463
5628
0.76
5.95
3.2
3.4
mg/l
473.3
264.9
0.47
319
3923
(3043410) Blood group antigens tested for on Red Blood Cells
18
49
3.70
5.92
2.1
2.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
77
427
1.84
5.84
3.9
3.6
mmol/l
7.1
7.7
1.46
77
413
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
427
3422
1.33
5.81
4.1
4.3
ng/l
246.2
721.5
1.19
380
3057
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
252
1872
1.40
5.53
3.8
3.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
497
5937
0.77
5.48
4.0
4.2
mg/mmol
8.7
10.9
0.75
328
4088
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
26
97
2.71
5.18
1.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
26
97
2.71
5.18
1.2
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
26
97
2.71
5.18
1.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
26
97
2.71
5.18
1.2
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
53
272
1.98
5.10
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
188
1353
1.44
4.93
2.4
2.5
u/l
29.5
41.3
1.64
162
1161
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
43
207
2.10
4.92
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
112
2.52
4.88
1.7
3.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62
341
1.85
4.87
1.4
1.7
—
—
—
0
0
(3010421) pH of Blood
85
514
1.69
4.84
3.2
5.6
ph
7.4
7.4
1.69
80
442
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
369
2967
1.31
4.81
1.6
1.7
mg/l
2.4
1.6
2.14
308
2375
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
44
216
2.06
4.80
1.4
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
82
493
1.70
4.78
3.2
4.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
43
211
2.06
4.70
1.4
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
43
212
2.05
4.64
1.4
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
45
227
2.01
4.57
2.2
4.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
77
466
1.68
4.40
2.6
2.6
%
15.3
16.0
0.99
40
253
(3022621) pH of Urine by Test strip
144
1010
1.46
4.34
2.8
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
477
4009
1.26
4.34
4.5
3.9
estimate
0.0
0.0
0.20
198
1243
(3020779) Urea [Moles/volume] in Serum or Plasma
255
1975
1.34
4.30
5.6
7.8
mmol/l
11.1
11.6
0.50
238
1872
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
179
1316
1.40
4.18
3.0
3.8
mmol/l
1.7
1.8
0.04
126
933
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
582
5035
1.23
4.04
2.0
2.1
nmol/l
81.7
76.5
3.82
513
4341
(3002256) Pathology report gross observation
274
2165
1.32
4.02
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
211
1.97
3.98
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
41
213
1.95
3.88
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
41
213
1.95
3.88
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
87
1307
0.65
3.83
1.7
1.7
%
1.6
1.8
1.22
73
1063
(3015736) pH of Urine
611
5348
1.22
3.72
3.9
3.4
ph
5.7
5.9
—
6
7
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
184
1389
1.36
3.68
3.1
3.9
kpa
5.0
5.1
1.25
171
1282
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
128
913
1.43
3.57
2.6
4.3
mmol/l
23.5
23.9
1.08
118
804
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
118
1645
0.70
3.55
1.2
1.2
u/ml
15.7
13.0
0.10
31
558
(3009343) pH of Capillary blood
180
1371
1.35
3.41
3.1
3.9
ph
7.4
7.4
0.61
26
166
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
48
275
1.77
3.40
1.4
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
44
248
1.79
3.30
2.2
2.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
144
1066
1.38
3.27
1.4
1.7
g/l
1.9
1.5
3.20
116
910
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
119
854
1.42
3.23
2.8
2.8
u/ml
0.4
0.3
0.59
71
477
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
114
819
1.42
3.09
3.0
4.4
mmol/l
24.5
24.7
0.23
102
752
(3024354) Oxygen [Partial pressure] in Venous blood
193
1509
1.31
3.07
2.8
3.2
kpa
4.1
4.5
2.72
183
1451
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
346
1.64
3.05
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
31
160
1.95
3.05
1.3
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
56
347
1.63
3.02
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
48
286
1.70
3.00
3.2
3.5
%
60.2
58.4
0.42
48
286
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
52
317
1.66
2.99
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
379
0.44
2.96
1.8
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
70
460
1.54
2.96
2.4
2.2
g/l
123.5
128.4
0.97
55
339
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
209
0.33
2.93
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
133
1756
0.74
2.90
1.2
1.2
iu/ml
31.4
39.7
0.40
40
482
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
35
192
1.84
2.89
1.2
1.6
—
—
—
0
0
(44806118)
38
214
1.79
2.89
1.2
1.5
—
—
—
0
0
(44790049)
38
214
1.79
2.89
1.2
1.5
—
—
—
0
0
(44790047)
38
214
1.79
2.89
1.2
1.5
—
—
—
0
0
(44790048)
38
214
1.79
2.89
1.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
161
2065
0.76
2.87
1.5
1.5
g/l
2.7
3.0
1.13
86
1251
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
24
116
2.08
2.83
1.3
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
77
2.35
2.82
1.3
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
36
202
1.80
2.78
1.2
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
28
145
1.95
2.75
1.5
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
288
1.65
2.68
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
80
1133
0.69
2.67
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
1111
10454
1.17
2.62
4.7
4.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
68
0.00
2.60
0.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
126
950
1.35
2.60
4.1
3.5
e9/l
3.9
4.4
1.24
100
667
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
46
283
1.64
2.59
1.2
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
410
4684
0.84
2.56
2.8
3.2
umol/l
5677.9
6097.6
0.03
333
3989
(3008898) HLA-B27 [Presence]
8
211
0.38
2.54
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
75
2.28
2.51
1.3
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
75
2.28
2.51
1.3
1.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
21
102
2.07
2.47
3.3
3.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
23
116
2.00
2.46
1.3
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
26
138
1.90
2.41
1.3
1.8
u/field
1.8
1.4
—
5
47
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
138
1.90
2.41
1.2
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
66
0.00
2.40
0.0
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
90
2.12
2.39
1.1
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
526
0.58
2.38
2.1
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
317
0.47
2.33
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
171
2116
0.79
2.32
1.2
1.2
u/ml
0.9
2.1
2.83
28
517
(3051611) Lipemic interference index of Serum or Plasma
29
162
1.80
2.31
3.6
3.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
31
178
1.76
2.27
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
31
178
1.76
2.27
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
31
178
1.76
2.27
1.2
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
405
3553
1.18
2.26
2.0
1.8
nmol/l
1225.3
1152.3
0.71
311
2666
(3042936) Bacteria identified in Isolate by Culture
296
2529
1.21
2.21
1.8
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
31
180
1.74
2.19
3.2
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
862
9210
0.87
2.13
3.2
3.1
pmol/l
15.1
15.0
0.39
752
8079
(3030905) Polymorphonuclear cells [#/volume] in Blood
43
277
1.57
2.07
3.2
3.3
e9/l
4.4
4.4
0.00
43
277
(3003338) MCHC [Mass/volume]
1126
10695
1.15
2.07
42.5
25.0
g/l
329.5
333.1
30.96
1118
10607
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
9
209
0.43
2.07
1.9
1.5
u/l
10.3
13.3
—
9
200
(21494814) CD8 cells/100 lymphocytes in Specimen
13
56
2.33
2.05
1.5
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
46
302
1.54
2.04
1.3
1.3
—
—
—
0
0
(4034850)
30
490
0.61
2.02
24.5
12.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
558
5059
1.15
2.01
2.7
2.2
u/l
216.2
258.1
0.51
530
4725
(3037522) Nuclear Ab [Titer] in Serum
120
1519
0.77
1.98
1.2
1.3
titre
238.2
409.8
3.85
22
318
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
64
2.20
1.94
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1105
10504
1.14
1.94
3.2
4.1
mm/h
21.6
13.8
22.31
1001
9602
(3014051) Protein [Presence] in Urine by Test strip
50
339
1.49
1.93
2.4
2.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
46
307
1.51
1.91
5.2
6.7
mg/l
13.0
11.9
0.75
40
288
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
51
0.00
1.88
0.0
1.1
—
2.3
—
0
20
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
52
0.00
1.88
0.0
1.1
—
0.6
—
0
23
(21491868) Cryoglobulin [Mass/volume] in Serum
0
54
0.00
1.85
0.0
1.3
—
0.1
—
0
6
(3011288) Drugs identified in Urine by Screen method
0
54
0.00
1.85
0.0
1.9
—
—
—
0
0
(4211845)
17
87
1.96
1.80
3.2
3.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
37
239
1.56
1.79
2.2
2.1
mg/l
19.7
25.4
—
10
47
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
409
3656
1.16
1.78
2.2
1.8
pmol/l
415.5
26380974.0
2.84
344
3006
(3028433) Virus identified in Specimen by Culture
11
47
2.35
1.77
1.0
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
298
0.53
1.77
1.1
1.4
e6/l
11.8
39.6
0.70
11
235
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
298
0.53
1.77
1.4
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
743
6914
1.13
1.76
2.0
2.1
pmol/l
88.1
90.3
0.65
457
3985
(3006462) Nitrate [Presence] in Urine
16
81
1.98
1.75
3.3
3.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
140
1137
1.25
1.74
2.3
4.7
ng/l
119.5
111.6
0.24
120
990
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
47
0.00
1.70
0.0
1.3
—
—
—
0
0
(4010399)
85
1101
0.76
1.70
1.5
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
8
180
0.44
1.69
6.0
3.6
mg/l
37.6
32.6
—
8
154
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
24
141
1.71
1.68
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
392
0.61
1.66
1.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
198
1677
1.20
1.65
4.7
8.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
83
635
1.32
1.65
1.3
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
347
3084
1.16
1.63
2.2
2.0
s
30.3
30.3
0.02
336
2993
(3022313) Gas panel - Capillary blood
122
984
1.26
1.62
3.4
4.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
18
99
1.83
1.57
2.3
4.4
nmol/l
78.8
168.8
1.17
18
99
(3022217) INR in Platelet poor plasma by Coagulation assay
320
2838
1.16
1.55
28.6
30.4
inr
1.3
1.5
2.13
58
402
(3026389) Candida sp identified in Specimen by Organism specific culture
24
145
1.66
1.54
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
106
1313
0.79
1.51
1.5
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
235
2039
1.18
1.51
4.2
5.0
%
31.8
32.5
0.39
158
1355
(3023419) Bacteria identified in Sputum by Culture
15
269
0.55
1.50
2.3
2.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
45
0.00
1.50
0.0
1.4
—
145.2
—
0
36
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
45
0.00
1.50
0.0
1.1
—
0.5
—
0
15
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
127
0.39
1.49
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
133
1097
1.23
1.47
2.5
3.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
178
2085
0.84
1.47
10.2
8.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
140
1.65
1.45
1.4
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
67
874
0.76
1.45
1.7
2.0
g/l
0.9
1.5
3.65
59
798
(3005719) IgG [Mass/volume] in Serum or Plasma
88
1107
0.78
1.44
1.9
2.5
g/l
9.6
10.9
2.53
76
1008
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
110
1.74
1.43
1.5
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
110
1.74
1.43
1.5
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
33
482
0.68
1.41
1.7
1.7
nmol/l
44.9
47.2
0.26
33
450
(3044290) Cell count panel - Cerebral spinal fluid
16
276
0.58
1.41
1.0
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
23
2.61
1.37
1.8
2.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
37
0.00
1.34
0.0
11.0
—
5.6
—
0
37
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
321
0.62
1.34
1.3
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
12
61
1.97
1.33
1.6
2.1
%
7.6
7.9
0.05
12
56
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
40
0.00
1.32
0.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
82
649
1.28
1.32
2.0
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
307
0.61
1.31
1.2
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
15
83
1.81
1.31
1.3
1.3
u/field
2.3
2.7
—
7
55
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
24
2.51
1.30
1.2
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
24
2.51
1.30
1.8
2.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
59
447
1.33
1.30
2.8
2.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
40
284
1.42
1.30
1.3
1.4
mmol/l
61.6
65.9
0.30
33
236
(3021879) Hepatitis B virus core Ab [Presence] in Serum
56
736
0.75
1.30
1.4
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
574
0.73
1.26
1.7
2.4
ug/min
58.1
114.6
1.59
22
344
(3014111) Lactate [Moles/volume] in Serum or Plasma
201
1750
1.17
1.26
4.2
7.2
mmol/l
1.3
1.4
2.31
191
1686
(3023410) Appearance of Cerebral spinal fluid
5
119
0.42
1.24
1.0
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
119
1419
0.83
1.22
4.1
4.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
11
56
1.97
1.22
1.2
1.1
g/l
39.3
39.4
—
6
26
(3048689) Calprotectin [Mass/mass] in Stool
92
1123
0.81
1.19
2.3
2.3
ug/g
163.5
194.6
0.38
69
887
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
225
0.57
1.19
1.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
38
2.11
1.18
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
322
0.65
1.18
1.2
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
272
0.62
1.15
1.2
1.5
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
35
0.00
1.15
0.0
1.3
—
142.7
—
0
8
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1363
13291
1.12
1.14
6.5
7.1
mmol/mol
41.9
41.6
0.32
1228
12075
(40768443) Skin Pathology biopsy report
51
662
0.76
1.11
1.4
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
181
0.55
1.08
1.2
1.1
—
33.4
—
0
11
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1351
13821
0.90
1.07
4.7
5.6
mmol/l
2.5
2.4
4.66
1168
12442
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
123
0.49
1.05
1.2
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
74
599
1.25
1.03
3.1
3.3
mmol/l
24.5
24.7
0.09
66
520
(3021387) Prolactin [Units/volume] in Serum or Plasma
12
203
0.59
1.03
2.0
1.7
mu/l
326.8
298.2
0.16
12
193
(40761535) Cells panel - Urine sediment
169
1481
1.16
1.01
3.8
3.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
109
0.46
1.00
1.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
35
2.00
1.00
1.1
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
64
512
1.26
0.99
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
42
549
0.76
0.99
1.8
3.6
—
—
—
0
0
(1002224) Polysomnography panel
21
308
0.68
0.98
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
29
0.00
0.97
0.0
1.4
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
2.3
—
147.8
—
0
24
(3036071) Salmonella sp Ab [Titer] in Serum
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1393
13635
1.11
0.97
4.8
5.3
mmol/l
6.3
6.2
0.66
1217
12143
(3014007) Fractional oxyhemoglobin in Arterial blood
111
1295
0.85
0.94
5.8
9.3
%
93.3
93.8
0.35
111
1289
(21494890) Protein electrophoresis panel - 24 hour Urine
17
257
0.66
0.93
1.2
2.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
142
0.56
0.93
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
144
0.55
0.93
1.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
180
2024
0.88
0.93
1.2
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
194
1729
1.14
0.93
3.4
2.6
g/l
65.0
65.8
0.72
166
1579
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
52
1.73
0.92
3.7
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
113
969
1.18
0.91
1.1
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
14
218
0.64
0.89
1.8
1.3
u/l
10.4
14.2
0.83
14
202
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1303
13316
0.91
0.88
4.4
5.0
mmol/l
1.3
1.3
2.65
1130
11941
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
128
0.55
0.88
1.0
1.1
—
33.9
—
0
6
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
403
0.74
0.87
1.2
1.6
—
—
—
0
0
(4133840)
6
31
1.94
0.84
1.5
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
24
331
0.72
0.83
1.4
1.2
nmol/l
0.9
0.8
0.39
17
274
(4268621)
6
112
0.53
0.83
3.0
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
214
0.65
0.83
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
46
576
0.79
0.81
1.6
1.6
u/l
38.5
36.5
0.29
39
481
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
150
1331
1.14
0.79
5.9
3.0
ml/min/173m2
60.4
59.1
0.19
69
573
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
235
0.68
0.79
1.3
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
66
1.67
0.78
1.3
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
66
1.67
0.78
1.3
2.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
246
0.69
0.78
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
123
0.57
0.78
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
124
0.56
0.77
2.3
2.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
222
0.67
0.77
1.1
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
60
722
0.82
0.75
1.6
3.5
mg/l
119.7
68.4
0.28
50
582
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
2.4
3.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
289
0.72
0.74
1.1
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
102
886
1.16
0.73
2.2
2.7
%
0.7
0.7
0.70
97
848
(3000494) Fungus identified in Specimen by Culture
163
1812
0.89
0.73
1.4
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
16
108
1.49
0.73
1.4
2.3
%
70.3
71.2
0.10
16
101
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
59
709
0.83
0.73
1.6
3.5
ratio
2.0
3.0
—
5
53
(3023183) Ammonium ion [Moles/volume] in Plasma
57
470
1.22
0.73
1.4
2.6
umol/l
30.3
35.2
0.73
48
386
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
38
478
0.79
0.72
1.1
1.3
—
6.7
—
0
8
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
21
287
0.73
0.71
1.1
1.1
—
43.2
—
0
10
(46235355) HIV 1 and 2 tests - Meaningful Use set
128
1441
0.88
0.71
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
20
275
0.72
0.71
1.3
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
10
157
0.63
0.69
1.9
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
77
1.56
0.68
2.1
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
178
1614
1.11
0.68
1.4
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
7
119
0.59
0.67
1.0
1.5
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
15
102
1.47
0.67
2.4
2.0
e9/l
0.1
0.1
0.80
15
95
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1271
12954
0.93
0.67
4.0
4.5
mmol/l
1.4
1.3
4.90
1095
11539
(3011397) Hemoglobin [Presence] in Urine by Test strip
355
3330
1.08
0.67
3.8
3.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
80
688
1.17
0.67
3.2
3.7
u/ml
236.9
7305.9
1.04
67
582
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
64
755
0.84
0.67
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
108
1221
0.88
0.65
1.4
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
61
721
0.84
0.65
1.6
3.5
mg/l
230.1
54.4
0.45
52
587
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
20
270
0.74
0.64
1.6
1.4
u/l
305.6
349.7
0.32
20
258
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
359
0.78
0.63
1.3
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
49
1.64
0.62
1.4
2.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
49
1.64
0.62
3.5
7.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
49
1.64
0.62
7.4
5.7
%
13.5
13.4
—
8
49
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1322
13441
0.93
0.62
4.3
5.0
mmol/l
4.4
4.2
9.81
1145
12195
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
178
1626
1.11
0.61
1.9
2.3
g/l
0.2
0.2
0.36
164
1490
(3005322) IgE [Units/volume] in Serum or Plasma
47
564
0.83
0.60
1.4
1.3
u/ml
384.7
277.5
0.21
42
508
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
6.8
—
—
—
0
0
(3025315) Body weight
0
20
0.00
0.60
0.0
2.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
203
2202
0.91
0.60
5.2
7.5
%
94.5
95.2
0.70
191
2116
(4024509)
9
141
0.64
0.60
1.1
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
67
778
0.86
0.60
2.8
2.7
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
22
0.00
0.59
0.0
4.9
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
26
201
1.30
0.59
1.2
1.5
%
71.7
65.6
0.37
18
121
(3037756) Immunofixation for Serum or Plasma
38
464
0.81
0.58
1.2
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
53
1.51
0.58
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
112
0.62
0.58
1.4
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
242
0.74
0.58
1.2
1.3
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
7
115
0.61
0.57
1.0
1.1
—
104.0
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
6
35
1.72
0.57
1.0
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
86
0.58
0.56
1.2
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
182
1976
0.91
0.56
5.3
8.1
g/l
113.0
122.0
8.15
176
1902
(3034770) Mitochondria Ab [Titer] in Serum
29
362
0.80
0.55
1.1
1.2
—
1361.3
—
0
8
(4062490)
8
124
0.64
0.54
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
97
0.62
0.52
1.3
1.4
umol/l
16.9
16.3
—
6
89
(40757373) Influenza virus identified in Isolate
6
40
1.50
0.51
2.3
1.6
—
—
—
0
0
(3036489) Thrombin time
65
565
1.16
0.51
1.8
1.9
s
21.8
22.1
0.17
60
518
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
112
1237
0.90
0.50
1.3
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
94
841
1.12
0.49
2.6
2.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
7
108
0.65
0.48
2.4
2.0
—
31.3
—
0
8
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
46
1.52
0.48
1.6
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
55
634
0.86
0.47
2.8
3.1
g/l
0.2
0.3
1.51
24
282
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
146
1.30
0.47
1.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
117
0.68
0.46
2.4
3.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
24
298
0.80
0.45
1.2
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
83
0.60
0.45
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
28
341
0.82
0.45
1.9
1.8
pmol/l
107.4
203.8
4.10
22
312
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
50
1.40
0.45
1.7
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
207
0.77
0.42
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
173
1853
0.93
0.42
2.8
2.4
ug/l
4.7
8.2
5.25
152
1635
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
39
456
0.85
0.42
3.0
2.8
mg/l
1.9
1.8
0.17
34
400
(3005011) Chlamydia sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.0
—
1.3
—
0
8
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
214
2014
1.07
0.41
1.8
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
16
123
1.30
0.40
3.2
2.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
54
613
0.88
0.40
3.0
3.9
mmol/l
3.9
4.0
0.48
47
563
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
171
0.76
0.39
1.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
35
1.43
0.39
1.6
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
61.9
—
0
12
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1188
12048
0.96
0.37
3.7
4.0
mu/l
2.1
2.1
0.07
1032
10636
(3000012) Reticulocyte production index
14
107
1.31
0.37
1.1
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
48
422
1.14
0.36
2.2
3.4
u/ml
54.7
711.0
1.61
41
394
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
99
1.32
0.35
2.1
2.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
199
1.21
0.35
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
126
0.71
0.35
1.1
1.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
31
361
0.86
0.33
1.2
1.2
titre
280.0
99.6
—
6
25
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
321
1.16
0.33
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
144
0.76
0.33
1.1
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
122
1309
0.93
0.33
5.4
6.8
mmol/l
23.8
24.3
0.46
114
1220
(3004616) Nuclear Ab [Presence] in Serum
12
155
0.77
0.33
1.3
1.2
—
—
—
0
0
(44813793)
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
6
86
0.70
0.33
1.0
1.1
—
12.0
—
0
24
(3006653) Thiamine [Moles/volume] in Blood
6
90
0.67
0.32
1.0
1.1
nmol/l
143.8
139.9
—
6
90
(3000475) Leukocytes [#/volume] in Synovial fluid
38
434
0.87
0.32
1.4
1.6
e6/l
13703.5
15441.1
0.18
28
306
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
108
1162
0.92
0.32
6.4
9.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
323
1.15
0.31
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
73
797
0.91
0.30
3.8
4.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
59
534
1.11
0.30
1.2
2.5
g/l
0.0
0.0
0.00
48
495
(4094501)
45
401
1.13
0.29
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
152
0.79
0.29
1.6
1.2
u/ml
2.2
6.1
—
5
71
(3033799) Differential panel - Peritoneal fluid
7
57
1.23
0.29
1.7
2.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
110
0.73
0.29
1.5
1.2
%
90.4
90.7
—
8
100
(3012441) Differential panel - Pleural fluid
26
302
0.86
0.28
1.2
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
317
1.14
0.28
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
149
1.21
0.28
2.2
2.2
e9/l
0.8
1.0
0.71
11
87
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
374
0.88
0.27
1.4
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
28
243
1.15
0.27
1.3
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
46
414
1.11
0.26
2.9
1.7
—
—
—
0
0
(4015189)
8
67
1.19
0.26
1.6
1.5
—
—
—
0
0
(44806420)
5
71
0.70
0.26
2.0
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
372
3833
0.96
0.26
3.3
3.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
37
414
0.89
0.25
3.3
3.0
nmol/l
0.8
0.8
0.08
23
310
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
393
0.89
0.25
1.3
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
45
497
0.90
0.25
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
13
105
1.24
0.24
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
513
1.09
0.24
3.6
3.5
pmol/l
4.4
4.3
0.24
51
446
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
32
360
0.89
0.24
1.2
1.2
—
258.3
—
0
12
(3042631) Mycobacterium sp identified in Specimen
34
303
1.12
0.23
1.7
2.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
106
1.23
0.23
2.8
2.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
37
411
0.90
0.23
1.4
3.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
5
40
1.25
0.22
1.0
1.5
g/l
20.7
24.9
—
5
34
(4306422)
12
146
0.82
0.22
1.5
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.8
—
15.5
—
0
11
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
9.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
8.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
59
546
1.08
0.21
1.2
2.5
g/l
0.0
0.0
0.50
48
495
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
63
585
1.08
0.21
1.2
2.5
g/l
0.0
0.0
0.01
52
533
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
145
0.83
0.21
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
0.5
—
0
8
(3024316) Viscosity of Plasma
0
14
0.00
0.20
0.0
1.4
—
1.7
—
0
5
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
108
1.21
0.20
3.4
2.0
e6/l
348.7
593.2
—
7
50
(3003327) Ova and parasites identified in Stool by Light microscopy
26
292
0.89
0.20
2.5
1.6
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
6
50
1.20
0.19
1.3
2.6
mmol/l
7.4
8.5
—
6
28
(3044242) Glucose [Moles/volume] in Arterial blood
14
118
1.19
0.19
1.5
2.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
154
0.84
0.19
2.5
1.3
nmol/l
0.8
0.7
0.63
13
145
(4146454)
19
217
0.87
0.18
3.1
2.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
290
1.11
0.18
2.5
1.3
u/l
7.3
7.7
0.07
17
233
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
10
121
0.83
0.18
1.0
1.1
mmol/l
3.0
2.1
—
10
109
(3017569) Oxygen content in Arterial blood
10
121
0.83
0.18
1.7
2.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
60
1.17
0.17
2.7
2.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
62
1.13
0.17
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
42
388
1.08
0.17
3.9
3.5
mg/l
35.4
34.8
0.04
30
253
(3027801) Oxygen [Partial pressure] in Arterial blood
232
2386
0.97
0.16
4.9
7.3
kpa
11.4
11.8
0.70
220
2275
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
141
0.85
0.16
2.5
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
232
2385
0.97
0.16
4.9
7.3
kpa
4.8
5.1
3.20
219
2272
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
92
1.20
0.16
1.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
92
1.20
0.16
1.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
77
0.78
0.15
1.0
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
71
673
1.06
0.15
1.5
2.7
g/l
1.2
1.4
0.14
54
574
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
27
296
0.91
0.15
1.2
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
188
1.12
0.14
1.4
1.7
iu/l
4.7
4.5
—
8
58
(3023383) Lactate [Moles/volume] in Pleural fluid
7
86
0.81
0.14
2.1
1.5
mmol/l
3.6
3.5
—
7
75
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
88
0.79
0.14
1.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
138
1427
0.96
0.14
1.5
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
96
0.83
0.13
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
72
755
0.95
0.13
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
438
0.93
0.13
1.1
1.2
iu/ml
93.6
117.5
0.25
14
131
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
117
0.85
0.13
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
107
0.84
0.13
1.0
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
63
600
1.05
0.12
1.2
2.4
g/l
35.3
37.1
1.49
48
518
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
137
0.88
0.12
2.5
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
10
116
0.86
0.12
1.2
1.3
—
32.5
—
0
8
(3003396) Base excess in Arterial blood by calculation
233
2380
0.98
0.12
4.9
7.3
mmol/l
0.8
1.0
0.27
175
1815
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
12
105
1.14
0.11
3.0
2.2
e6/l
377.8
540.5
0.63
12
93
(3023199) Leukocytes [#/volume] in Pleural fluid
31
332
0.93
0.11
1.5
1.5
e6/l
1508.9
1826.8
0.34
26
240
(3051593) INR in Capillary blood by Coagulation assay
10
115
0.87
0.10
8.2
14.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
52
495
1.05
0.10
1.4
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
308
3126
0.98
0.09
4.7
4.1
kg/l
1.0
1.0
0.58
66
491
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
20
217
0.92
0.09
1.1
1.1
iu/ml
1.2
32.0
—
6
40
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
32
301
1.06
0.09
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
144
0.90
0.08
1.2
2.0
%
7.0
10.8
2.13
13
144
(4281824)
5
61
0.82
0.08
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
185
1.08
0.08
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
328
0.94
0.08
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
40
381
1.05
0.08
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
244
1.07
0.08
3.8
4.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
27
254
1.06
0.07
1.6
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
72
0.83
0.07
1.2
1.7
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
6
75
0.80
0.07
1.0
1.3
%
—
55.8
—
0
12
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
90
0.89
0.06
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
295
1.05
0.06
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
790
0.97
0.06
1.4
2.5
g/l
8.5
7.3
2.90
50
585
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
213
0.94
0.06
4.3
3.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
789
0.97
0.05
1.4
2.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
61
627
0.97
0.05
5.2
6.5
mmol/l
1.4
1.4
0.01
56
549
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
788
0.98
0.05
1.4
2.5
g/l
4.4
3.8
0.54
49
566
(3028308) Erythrocytes [#/volume] in Pleural fluid
29
303
0.96
0.05
1.5
1.5
e6/l
55343.8
67532.9
0.12
18
187
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
734
1.02
0.04
1.5
2.5
g/l
9.6
10.5
1.06
54
621
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
114
1122
1.02
0.04
5.5
9.4
mmol/l
23.6
24.2
0.96
106
1050
(3000570) Elastase.pancreatic [Mass/mass] in Stool
44
427
1.03
0.04
1.4
1.5
ug/g
266.3
248.1
0.28
30
279
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
119
0.92
0.04
1.1
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
32
309
1.04
0.03
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
139
0.93
0.03
1.3
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
230
1.04
0.03
1.2
1.2
u/ml
316.6
281.6
0.23
11
136
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
252
1.03
0.02
1.2
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
103
1.07
0.02
1.0
1.1
—
31.6
—
0
5
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
177
0.96
0.01
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
56
552
1.01
0.01
1.5
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
104
1.06
0.01
1.6
2.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
14
146
0.96
0.00
1.1
1.2
nmol/l
475.1
318.9
—
9
109
(3001019) Free T4 and TSH panel - Serum or Plasma
15
145
1.03
0.00
1.7
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
15
155
0.97
0.00
1.8
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
10
99
1.01
0.00
2.6
2.2
e9/l
0.2
0.2
—
10
92
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
185
1.03
0.00
1.7
3.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
215
0.98
0.00
1.2
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
28
285
0.98
0.00
1.3
1.4
—
20.7
—
0
9
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
221
1.00
0.00
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
286
1.01
0.00
1.3
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
728
1.00
0.00
1.5
2.5
g/l
3.7
3.0
3.83
50
574
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
118
1.02
0.00
1.0
1.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
90.6
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
5
57
0.88
0.00
1.2
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
7
0.00
0.00
0.0
8.3
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
4.8
—
342.8
—
0
6
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
53
0.94
0.00
1.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
65.5
—
0
6
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
13
130
1.00
0.00
1.4
1.3
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
842.0
—
0
5
(40768795) Lymph node Pathology biopsy report
12
120
1.00
0.00
1.3
1.2
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.2
—
0
5
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
2.1
—
1.4
—
0
9
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
7.2
—
67.6
—
0
5
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
85
0.94
0.00
1.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
74
0.95
0.00
2.1
1.4
%
28.7
24.1
—
7
57
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
24
240
1.00
0.00
1.3
1.5
u/ml
107.3
120.0
—
6
54
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
85
0.94
0.00
1.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
92
0.98
0.00
3.7
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
66
0.91
0.00
1.0
1.2
iu/ml
86.3
259.4
—
6
66
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
7
79
0.89
0.00
1.4
1.6
nmol/l
11.0
13.7
—
7
70
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
2.0
—
0
5
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
1.7
—
0
5
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
2.5
—
0
5
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_L02BX – L02BX Other hormone antagonists and related agents

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).